ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) today announced that it will release complete financial results for the three and nine months ended June 30, 2007 before market open on Wednesday, August 8, 2007. Keith Katkin, President and Chief Executive Officer, Martin Sturgeon, Vice President and Interim Chief Financial Officer, and Randall Kaye, M.D., Senior Vice President and Chief Medical Officer, will host an investment community conference call that same day at 8:00 a.m. Pacific time / 11:00 a.m. Eastern time to discuss those results and answer questions.
